We have a new product, OSMOMED. It is a digital laboratory for research programs in biomedicine and drug development.
In R&D projects, results are usually scattered across programs, spreadsheets, and correspondence. After six months, it is difficult to remember why a particular decision was made. OSMOMED brings everything together in one workspace: target validation, literature and patents, molecular calculations, laboratory data, and clinical trial planning. Each step is recorded in a history with the author, timestamp, and rationale.
For clients, this means a faster path from idea to new candidate compound and less time spent on routine tasks. The system handles the computational part itself, filtering out weak ideas before expensive experiments, so results do not have to be manually gathered from different programs. Research proceeds faster, and decisions are based on the preserved history.
The system performs the calculations, while experiments and key decisions remain with the specialists. When new data appears, the calculation can be repeated or the candidate can be reconsidered. Previous results are preserved in the process. At the end, a research summary and a dossier with decisions and calculations are generated.
The platform features an integrated chat agent based on a language model. It answers questions about the progress of the research based on program data and helps with navigation. It runs locally on the client's servers, and you can connect your own model.
Analytics and the agent connect to systems already present in the company: LIMS, ELN, molecular databases, and instrument software. Data remains within the perimeter.
OSMOMED runs on the OSMOCV platform. The interface is available in Russian, English, Chinese, and other languages.
Want to see the product in action? We will show a demonstration program from the first step to the final result.
The product was created on September 15, 2026.
